Merck
MRK
#46
Rank
NZ$520.41 B
Marketcap
NZ$208.35
Share price
0.15%
Change (1 day)
33.75%
Change (1 year)

EPS for Merck (MRK)

EPS in 2025 (TTM): NZ$12.54

According to Merck's latest financial reports the company's current EPS (TTM) is NZ$12.28. an increase over its 2024 EPS that were of NZ$11.36.

EPS history for Merck from 2011 to 2025

Annual EPS

Year EPS Change
2025NZ$12.237.71%
2024NZ$11.364308.46%
2023NZ$0.26-97.32%
2022NZ$9.6310.92%
2021NZ$8.6884.68%
2020NZ$4.70-27.2%
2019NZ$6.4663.44%
2018NZ$3.95151.11%
2017NZ$1.57-54.58%
2016NZ$3.4630.21%
2015NZ$2.66-61.99%
2014NZ$7.00180.51%
2013NZ$2.49-31.82%
2012NZ$3.666.62%
2011NZ$3.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$18.71 52.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.37 0.73%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.28-81.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.30-48.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.68 215.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.08 96.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.47-71.74%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
NZ$4.99-59.35%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.33-48.43%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$2.08-83.03%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel